Carson Wealth (CWM LLC)’s Virtus Biotech ETF BBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.6K Hold
717
﹤0.01% 3681
2025
Q4
$57K Hold
717
﹤0.01% 3495
2025
Q3
$50K Hold
717
﹤0.01% 3531
2025
Q2
$42K Hold
717
﹤0.01% 3406
2025
Q1
$42K Hold
717
﹤0.01% 3107
2024
Q4
$43K Hold
717
﹤0.01% 2908
2024
Q3
$45K Hold
717
﹤0.01% 2761
2024
Q2
$42K Hold
717
﹤0.01% 2593
2024
Q1
$41K Buy
717
+167
+30% +$9.74K ﹤0.01% 2423
2023
Q4
$32K Hold
550
﹤0.01% 2458
2023
Q3
$28K Hold
550
﹤0.01% 2444
2023
Q2
$29K Hold
550
﹤0.01% 2385
2023
Q1
$27K Hold
550
﹤0.01% 2280
2022
Q4
$27K Hold
550
﹤0.01% 2144
2022
Q3
$25K Buy
550
+300
+120% +$13.9K ﹤0.01% 2080
2022
Q2
$10K Buy
+250
New +$9.93K ﹤0.01% 2564

Other funds holding BBP

Carson Wealth (CWM LLC)'s BBP Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its Virtus Biotech ETF (BBP) position steady in Q1 2026 at 717 shares worth $59.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3681.

Carson Wealth (CWM LLC) first reported a position in BBP in Q2 2022 and has held it in 16 quarters since. 26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

  • Carson Wealth (CWM LLC) held 717 shares of Virtus Biotech ETF worth $59.6K as of Q1 2026.
  • Carson Wealth (CWM LLC) left its Virtus Biotech ETF share count unchanged in Q1 2026.
  • Virtus Biotech ETF made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3681 holding.
  • Carson Wealth (CWM LLC) first reported a position in Virtus Biotech ETF in Q2 2022 and has held it in 16 quarters since.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.